AKAM vs ANSS Stock Comparison
ANSS currently leads AKAM in this stock comparison, with AIQ scores of 56 vs 41. The clearest difference is risk resilience, while AKAM has the stronger value profile.
What is the main difference between AKAM and ANSS?
ANSS leads the current stock comparison as ANSYS, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Akamai Technologies, Inc. vs ANSYS, Inc.
ANSS leads
ANSS leads by 15 AIQ points, primarily on Risk Resilience and Quality, and the lead has widened from 10 points over 30 sessions. Wall Street currently favors AKAM on target upside.
Stable: 3 of 5 evidence groups support ANSS, and its lead is widening.
Akamai Technologies, Inc.
ANSYS, Inc.
The Algovestiq AIQ Score currently favors ANSS over AKAM, 56 versus 41 as of Oct 22, 2026. ANSS's advantage is driven primarily by stronger risk resilience and quality, while AKAM holds the stronger value profile. Analyst target upside, however, currently favors AKAM. 3 of 5 covered evidence groups favor ANSS today, and the comparison is rated Stable on stability. ANSS lead: Strengthening — the AIQ differential moved from 10 to 15 points over 30 sessions.
Compare Akamai Technologies, Inc. and ANSYS, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare AKAM and ANSS against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience34 vs 90ANSS +56
- Value69 vs 27AKAM +42
- Quality34 vs 68ANSS +34
3 of 5 evidence groups favor ANSS. ANSS’s edge is concentrated in risk resilience and quality; AKAM keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +1
No signal started or stopped since the prior session; its 7 active signals are unchanged.
No factor moved materially.
No signal started or stopped since the prior session.
ANSS's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — AKAM and ANSS both carry a full feed there.
The central trade-off
ANSS (ANSYS, Inc.): the stronger current systematic profile, led by risk resilience and quality.
AKAM (Akamai Technologies, Inc.): the counter-case, on value, valuation, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
ANSSANSS on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AKAMAKAM on combined revenue and EPS growth.
Value
AKAMAKAM on the peer-relative Value factor, by 42 points.
Momentum
EvenThe two are level on Momentum.
Lower downside
ANSSANSS on Risk Resilience, by 56 points.
Analyst upside
AKAMAKAM on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ANSS, analyst targets favor AKAM. That disagreement is the most useful thing on this page.
| Measure | AKAM | ANSS | Note |
|---|---|---|---|
| Implied upside to target | +79.2% | +5.8% | AKAM has more room |
| Target dispersion | +63.1% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 15 | 1 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor ANSS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | ANSS | 41 vs 56 |
| Fundamentals | ANSSon balance | revenue growth 2.4% vs -42.8%; EPS growth -24.7% vs -81.7%; TTM ROE 8.5% vs 10%; gross margin 56.4% vs 89%; operating margin 11.8% vs 28.2% — ANSS takes 3 of 5 decided legs, not all of them |
| Valuation | AKAM | Value 69 vs 27 |
| Technicals | Not covered | Not covered |
| Risk Resilience | ANSS | Risk Resilience 34 vs 90 |
| Analyst expectations | AKAM | Target upside 79.2% vs 5.8% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AKAM and ANSS and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 15 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ANSS.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20ANSS lead: Strengthening — the AIQ differential moved from 10 to 15 points over 30 sessions.
- Today
- ANSS +15
- 41 vs 56
- 7 sessions ago
- ANSS +15
- 41 vs 56
- 30 sessions ago
- ANSS +10
- 46 vs 56
- 90 sessions ago
- ANSS +1
- 54 vs 55
The lead changed hands once in this window, most recently on Sep 24 when ANSS moved ahead of AKAM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 5 bearish / 1 neutral, conflicted
Only AKAM
- Death Cross Active — bearish, trend, long horizon (4.23%)
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (6.65%)
- Keltner Channel Breakdown — bearish, volatility, short horizon
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
- Beta Spike Warning — bearish, risk, long horizon
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
No active signals
No signal that the other name lacks.
AKAM is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +0.71%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AKAM closes the Risk Resilience gap — currently 56 points behind, the largest single contributor to ANSS's edge.
- 2AKAM's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3ANSS starts generating bearish momentum or trend signals.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
ANSS leads on balance| Metric | AKAM | ANSS |
|---|---|---|
| Revenue growth (YoY) | 2.4% | -42.8% |
| EPS growth (YoY) | -24.7% | -81.7% |
| Gross margin | 56.4% | 89% |
| Operating margin | 11.8% | 28.2% |
| Return on equity (TTM) | 8.5% | 10% |
| Debt to equity | 1.97 | 0.14 |
Performance
Split across windows| Metric | AKAM | ANSS |
|---|---|---|
| 1 week (5 sessions) | -10.3% | — |
| 1 month (20 sessions) | -24.3% | — |
| 3 months (63 sessions) | -27.9% | — |
| 6 months (126 sessions) | -8.6% | — |
| Year to date | 2.7% | — |
| 1 year (252 sessions) | 22.8% | — |
Technicals
Split| Metric | AKAM | ANSS |
|---|---|---|
| RSI (14) | 29.7 | — |
| ADX (14) | 17.1 | — |
| Price vs 50-day | -16.2% | — |
| Price vs 200-day | -20.2% | — |
| Volatility (1M, annualized) | 56.2% | — |
Risk
ANSS is the more resilient| Metric | AKAM | ANSS |
|---|---|---|
| Beta | 1.44 | — |
| Sharpe ratio | 0.57 | — |
| Sortino ratio | 0.91 | — |
| Max drawdown | -45.9% | — |
| Current drawdown | -44.4% | — |
| Annualized volatility | 62% | — |
| Value at risk (95%) | -5.3% | — |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AKAM or ANSS?
On the Algovestiq AIQ Score, ANSS is the stronger of the two as of Oct 22, 2026, scoring 56 against AKAM's 41. The edge comes from risk resilience and quality. AKAM is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AKAM or ANSS the better buy right now?
ANSS carries the stronger systematic profile as of Oct 22, 2026, and the comparison is rated Stable — 3 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor ANSS over AKAM?
The composite weights Quality, Value, Momentum and Risk Resilience. ANSS leads Risk Resilience by 56 points; AKAM leads Value by 42 points; ANSS leads Quality by 34 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AKAM or ANSS?
Analyst price targets imply +79.2% upside for AKAM and +5.8% for ANSS, so the Street currently favors AKAM. That points the opposite way to the AIQ Score, which favors ANSS. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AKAM or ANSS?
AKAM is the better-valued of the two on the peer-relative Value factor. AKAM on the peer-relative Value factor, by 42 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AKAM or ANSS?
AKAM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AKAM or ANSS?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AKAM or ANSS?
ANSS is the more resilient of the two, so the other name carries the higher downside risk. ANSS on Risk Resilience, by 56 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AKAM more profitable than ANSS?
ANSS leads on the comparable margin measures — gross margin 56.4% vs 89%; operating margin 11.8% vs 28.2%; ttm roe 8.5% vs 10%.
Is ANSS's lead over AKAM getting stronger or weaker?
ANSS lead: Strengthening — the AIQ differential moved from 10 to 15 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has changed hands once in that window, most recently on 2026-09-24, when ANSS moved ahead of AKAM.
What would change the AKAM vs ANSS verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AKAM closes the Risk Resilience gap — currently 56 points behind, the largest single contributor to ANSS's edge; AKAM's Death Cross Active resolves — a bearish trend rule currently active against it; ANSS starts generating bearish momentum or trend signals; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about AKAM and ANSS?
AKAM: 1 bullish / 5 bearish / 1 neutral, conflicted. ANSS: No active signals. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AKAM is Death Cross Active (bearish, long horizon).
Compare AKAM and ANSS with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.